Toshikazu Nagao
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Toshikazu Nagao.
Nature Medicine | 2000
Hiroaki Higashitsuji; Katsuhiko Itoh; Toshikazu Nagao; Simon Dawson; Kohsuke Nonoguchi; Tsuneo Kido; R. John Mayer; Shigeki Arii; Jun Fujita
Hepatocellular carcinoma (HCC) is one of the most common cancers in Asia and Africa, where hepatitis virus infection and exposure to specific liver carcinogens are prevalent. Although inactivation of some tumor suppressor genes such as p53 and p16INK4Ahas been identified, no known oncogene is commonly activated in hepatocellular carcinomas. Here we have isolated genes overexpressed in hepatocellular carcinomas by cDNA subtractive hybridization, and identified an oncoprotein consisting of six ankyrin repeats (gankyrin). The expression of gankyrin was increased in all 34 hepatocellular carcinomas studied. Gankyrin induced anchorage-independent growth and tumorigenicity in NIH/3T3 cells. Gankyrin bound to the product of the retinoblastoma gene (RB1), increasing its phosphorylation and releasing the activity of the transcription factor E2F-1. Gankyrin accelerated the degradation of RB1 in vitro and in vivo, and was identical to or interacted with a subunit of the 26S proteasome. These results demonstrate the importance of ubiquitin–proteasome pathway in the regulation of cell growth and oncogenic transformation, and indicate that gankyrin overexpression contributes to hepatocarcinogenesis by destabilizing RB1.
Cancer Cell | 2002
Hisako Higashitsuji; Hiroaki Higashitsuji; Toshikazu Nagao; Kohsuke Nonoguchi; Shingo Fujii; Katsuhiko Itoh; Jun Fujita
NF-kappa B is a transcription factor that can protect from or contribute to apoptosis. Here we report identification of HSCO that binds to NF-kappa B and inhibits apoptosis. HSCO mRNA was overexpressed in 20 of 30 hepatocellular carcinomas analyzed. Overexpression of HSCO inhibited caspase 9 activation and apoptosis induced by DNA damaging agents, while it augmented apoptosis induced by TNFalpha. Like I kappa B alpha, HSCO inhibited NF-kappa B activity and abrogated p53-induced apoptosis. However, the underlying mechanism was different. HSCO is a nuclear-cytoplasmic shuttling protein, bound to RelA NF-kappa B, and HSCO sequestered it in the cytoplasm by accelerating its export from the nucleus. These results suggest that overexpression of HSCO suppresses p53-induced apoptosis by preventing nuclear localization of NF-kappa B during signaling and thus contributes to hepatocarcinogenesis.
International Journal of Urology | 1999
Hiromu Tokuchi; Hiroaki Higashitsuji; Hiroyuki Nishiyama; Kohsuke Nonoguchi; Toshikazu Nagao; Jing-Hui Xue; Katsuhiko Itoh; Osamu Ogawa; Jun Fujita
Background : The cytoplasmic‐type protein tyrosine phosphatase PTP‐RL10/PTPD1/PTP2E contains an ezrin‐like domain and associates with the c‐Src protein tyrosine kinase. Because tyrosine phosphorylation regulated by protein tyrosine kinases and phosphatases is involved in activation, migration, differentiation and proliferation of various cell types, the expression of PTP‐RL10 and c‐src in the mouse testis was investigated.
Neuroreport | 2007
Hiroshi Yoshimura; Yuichi Mashiyama; Keiseki Kaneyama; Toshikazu Nagao; Natsuki Segami
Traveling neural signals may try to find suitable paths of propagation in cortical circuits. We examined the behavior of electrically evoked signals from primary visual cortex (Oc1) to granular retrosplenial cortex (RSG) in rat brain slices under caffeine application. With continued electrical stimulation, evoked signals propagated from Oc1 to RSG along the upper layer of the secondary visual cortex (Oc2) and agranular retrosplenial cortex (RSA), but on further continuation of stimulation, a new shortcut pathway along the deep layer between Oc2 and RSG was opened. Circuitry changes reduced the signal traveling time by about 40 ms. Cortical neural circuits between Oc1 and RSG may thus have the ability to open a shortcut circuit in a use-dependent manner.
Cancer Cell | 2005
Hiroaki Higashitsuji; Hisako Higashitsuji; Katsuhiko Itoh; Toshiharu Sakurai; Toshikazu Nagao; Haruhiko Sumitomo; Tomoko Masuda; Simon Dawson; Yutaka Shimada; R. John Mayer; Jun Fujita
Journal of Biological Chemistry | 2003
Toshikazu Nagao; Hiroaki Higashitsuji; Kohsuke Nonoguchi; Toshiharu Sakurai; Simon Dawson; R. John Mayer; Katsuhiko Itoh; Jun Fujita
Journal of Biological Chemistry | 2004
Toshiharu Sakurai; Katsuhiko Itoh; Hiroaki Higashitsuji; Toshikazu Nagao; Kohsuke Nonoguchi; Tsutomu Chiba; Jun Fujita
Journal of Oral and Maxillofacial Surgery | 2007
Keiseki Kaneyama; Natsuki Segami; Jun Sato; Kazuma Fujimura; Toshikazu Nagao; Hiroshi Yoshimura
British Journal of Oral & Maxillofacial Surgery | 2007
Keiseki Kaneyama; Natsuki Segami; Tsurusako Shin-Ichi; Kazuma Fujimura; Jun Sato; Toshikazu Nagao
Molecular Therapy | 2003
Kanji Yamaguchi; Katsuhiko Itoh; Naoki Ohnishi; Yoshito Itoh; Christopher Baum; Takashi Tsuji; Toshikazu Nagao; Hiroaki Higashitsuji; Takeshi Okanoue; Jun Fujita